Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
Recruiting · NCT07270835 · Registry updated 2025-12-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphohistiocytosis, Hemophagocytic, Neoplasms by Histologic Type, histiocytosis, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Langerhans cell histiocytosis | Recruiting | Phase 4 | 2025-12-08 | NCT07270835 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 164 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Soochow University | Suzhou | China | 42 |